Effects of boron-containing compounds on immune responses: review and patenting trends

References

• Woods WG. An introduction to boron: history, sources, uses, and chemistry. Environ Health Perspect. 1994;102(S7):5–11.
   PubMedGoogle Scholar
• Kaup M, Schmid Y, Middleton M, et al. Borate in mummification salts and bones from Pharaonic Egypt. Inorg Biochem. 2003;94(3):214–220.
   PubMed Web of Science ®Google Scholar
• Uluisik I, Karakaya HC, Koc A. The importance of boron in biological systems. J Trace Elem Med Biol. 2018;45:156–162.
   PubMed Web of Science ®Google Scholar
• Khaliq H, Juming Z, Ke-Mei P. The physiological role of boron on health. Biol Trace Elem Res. 2018;186(1):31–51.
   PubMed Web of Science ®Google Scholar
• Nielsen FH. Boron in human and animal nutrition. Plant Soil. 1997;193:199–208.
   Web of Science ®Google Scholar
• Ocampo-Néstor AL, Trujillo-Ferrara JG, Abad-García A, et al. Boron‘s journey: advances in the study and application of pharmacokinetics. Expert Opin Ther Pat. 2017;27(2):203–215.
   PubMed Web of Science ®Google Scholar
• Naghii MR, Torkaman G, Mofid M. Effects of boron and calcium supplementation on mechanical properties of bone in rats. Biofactors. 2006;28(3‐4):195–201.
   PubMed Web of Science ®Google Scholar
• Nielsen FH. Update on human health effects of boron. J Trace Elem Med Biol. 2014;28(4):383–387.
   PubMed Web of Science ®Google Scholar
• Soriano-Ursúa MA, Das BC, Trujillo-Ferrara JG. Boron containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy. Expert Opin Ther Pat. 2014;4:485–500.
   Google Scholar
• Watson-Clark RA, Banquerigo ML, Shelly K, et al. Model studies directed toward the application of boron neutron capture therapy to rheumatoid arthritis: boron delivery by liposomes in rat collagen-induced arthritis. Proc Natl Acad Sci U S A. 1998;95(5):2531–2534.
   PubMed Web of Science ®Google Scholar
• Demirci S, Doğan A, Aydın S, et al. Boron promotes streptozotocin-induced diabetic wound healing: roles in cell proliferation and migration, growth factor expression, and inflammation. Mol Cell Biochem. 2016;417(1–2):119–133.
   PubMed Web of Science ®Google Scholar
• Routray I, Ali S. Boron induces lymphocyte proliferation and modulates the priming effects of lipopolysaccharide on macrophages. PLoS One. 2016;11(3):e0150607.
   Web of Science ®Google Scholar
• Doğan A, Demirci S, Apdik H, et al. A new hope for obesity management: boron inhibits adipogenesis in progenitor cells through the Wnt/β-catenin pathway. Metabolism. 2017;69:130–142.
   PubMed Web of Science ®Google Scholar
• López-Cabrera Y, Castillo-García EL, Altamirano-Espino JA, et al. Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats. J Trace Elem Med Biol. 2018;50:424–429.
   PubMed Web of Science ®Google Scholar
• Baker SJ; Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents. United States patent US8168614B2. 2007 Aug 23.
   Google Scholar
• Baker SJ, Sanders V, Akama T, et al. Boron-containing small molecules as anti-inflammatory agents. US20170258819. 2017 Sep 14.
   Google Scholar
• Sanders V; Anacor Pharmaceuticals, Inc. Compounds for the treatment of periodontal disease. United States Patent US20070286822A1. 2007 Dec 13.
   Google Scholar
• Aras MH, Sezer U, Erkilic S, et al. Effect of dietary boron on 5-fluorouracil induced oral mucositis in rats. Eur J Dent. 2013;7(3):310–314.
   PubMedGoogle Scholar
• Lehmann DM, Cavet ME, Richardson ME. Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, Biotrue™ multi-purpose solution. Cont Lens Anterior Eye. 2010;33(S1):24–32.
   Google Scholar
• Johnson K, Stollings JL, Ely EW. Breaking bad delirium: methamphetamine and boric acid toxicity with hallucinations and pseudosepsis. South Med J. 2017;110(2):138–141.
   PubMed Web of Science ®Google Scholar
• Colak S, Geyikoglu F, Keles ON, et al. The neuroprotective role of boric acid on aluminum chloride-induced neurotoxicity. Toxicol Ind Health. 2011;27(8):700–710.
   PubMed Web of Science ®Google Scholar
• Lin L, Zheng C, Zhang L, et al. 2-Aminoethoxydiphenyl borate administration into the nostril alleviates murine allergic rhinitis. Am J Otolaryngol. 2011;32(4):318–328.
   PubMed Web of Science ®Google Scholar
• Barth RF, Zhang Z, Liu T. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Commun. 2018;38:36.
   PubMed Web of Science ®Google Scholar
• Barth RF, Mi P, Yang W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun. 2018;38:35.
   PubMed Web of Science ®Google Scholar
• Nichols JJ, Sinnott LT, King-Smith PE, et al. Hydrogel contact lens binding induced by contact lens rewetting drops. Optom Vis Sci. 2008;85(4):236–240.
   PubMed Web of Science ®Google Scholar
• Hunt CD, Butte NF, Johnson LK. Boron concentrations in milk from mothers of exclusively breast-fed healthy full-term infants are stable during the first four months of lactation. J Nutr. 2005;135(10):2383–2386.
   PubMed Web of Science ®Google Scholar
• Fevig JM, Buriak J Jr, Cacciola J, et al. Rational design of boropeptide thrombin inhibitors: beta, beta-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profile. Bioorg Med Chem Lett. 1998;8(3):301–306.
   PubMed Web of Science ®Google Scholar
• Dong C, Sexton H, Gertrudes A, et al. Inhibition of Toll-like receptor-mediated inflammation in vitro and in vivo by a novel benzoxaborole. J Pharmacol Exp Ther. 2013;344(2):436–446.
   PubMed Web of Science ®Google Scholar
• Durick K, Tomita M, Santoro T, et al. Evidence that boron down-regulates inflammation through the Nf-(Kappa) b pathway. J Federation Am Soc Exp Biol. 2005;9(5):1705.
   Google Scholar
• Haseeb K, Wang J, Xiao K, et al. Effects of boron supplementation on expression of Hsp70 in the spleen of African ostrich. Biol Trace Elem Res. 2018;182(2):317–327.
   PubMed Web of Science ®Google Scholar
• Hunt CD. Dietary boron as a physiological regulator of the normal inflammatory response: a review and current research progress. J Trace Elem Med Biol. 2000;12(3):221–233.
   Google Scholar
• Xu Z. Effect of fluoride on the activity of NK cell and IL-2 and antagonistic effect of boron to fluoride in rats [J]. J Yunyiang Med Coll. 1995;01:1-5.
   Google Scholar
• Hunt CD. Dietary boron: an overview of the evidence for its role in immune function. J Trace Elem Med. 2005;16(4):291–306.
   Google Scholar
• Woolf CJ, Bean BP; Harvard College. Permanently charged sodium and calcium channel blockers as anti-inflammatory agents. WO2011006073A1. 2011 Jan 13
   Google Scholar
• Ng NM, Jiang SP, Zhang W. 2-Aminoethoxydiphenyl borate reduces degranulation and release of cytokines in a rat mast cell line. Eur Rev Med Pharmacol Sci. 2012;16(8):1017–1021.
   PubMed Web of Science ®Google Scholar
• Bakowski D, Glitsch MD, Parekh AB. An examination of the secretion-like coupling model for the activation of the Ca2+ release-activated Ca2+ current I(CRAC) in RBL-1 cells. J Physiol. 2001;1(532):55–71.
   Google Scholar
• Feng B, Li X, Li S, et al. Effect of drinking boron on blood composition in rats. Wei Sheng Yan Jiu. 2009;38(4):485–488.
   PubMedGoogle Scholar
• Al-Homsi AS, Goodyke A, Cole K, et al. Ixazomib suppresses human dendritic cell and modulates murine graft-versus-host disease in a schedule-dependent fashion. Exp Hematol. 2017;48:50–57.
   PubMed Web of Science ®Google Scholar
• Félix R, Crottès D, Delalande A, et al. The Orai-1 and STIM-1 complex controls human dendritic cell maturation. PLoS One. 2013;20:8–13.
   Google Scholar
• Hall IH, Burnham BS, Chen SY, et al. The anti-inflammatory activity of boron derivatives in rodents. Met Based Drugs. 1995;2(1):1–12.
   PubMedGoogle Scholar
• Hall IH, Rajendran KG, Chen SY, et al. Anti-inflammatory activity of amine-carboxyboranes in rodents. Arch Pharm (Weinheim). 1995;328(1):39–44.
   PubMed Web of Science ®Google Scholar
• Hall IH, Starnes CO, McPhail AT, et al. Anti-inflammatory activity of amine cyanoboranes, amine carboxyboranes, and related compounds. J Pharm Sci. 1980;69(9):1025–1029.
   PubMed Web of Science ®Google Scholar
• Conejeros I, Velásquez ZD, Carretta MD, et al. 2-Aminoethoxydiphenyl borate (2APB) reduces alkaline phosphatase release, CD63 expression, F-actin polymerization and chemotaxis without affecting the phagocytosis activity in bovine neutrophils. Vet Immunol Immunopathol. 2012;145(1–2):540–545.
   PubMed Web of Science ®Google Scholar
• Conejeros I, Jara E, Carretta MD, et al. 2-Aminoethoxydiphenyl borate (2APB) reduces respiratory burst, MMP-9 release and CD11b expression, and increases l-selectin shedding in bovine neutrophils. Res Vet Sci. 2012;92(1):103–113.
   PubMed Web of Science ®Google Scholar
• Achilli C, Jadhav SA, Guidetti GF, et al. Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets. Chem Biol Drug Des. 2014;83(5):532–572.
   PubMed Web of Science ®Google Scholar
• Bednarska K, Olejniczak AB, Piskala A, et al. Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophils. Bioorg Med Chem. 2012;20(22):6621–6630.
   PubMed Web of Science ®Google Scholar
• Lahiri D, Rouzaud F, Richard T, et al. Boron nitride nanotube reinforced polylactide-polycaprolactone copolymer composite: mechanical properties and cytocompatibility with osteoblasts and macrophages in vitro. Acta Biomater. 2010;6(9):3524–3533.
   PubMed Web of Science ®Google Scholar
• Horváth L, Magrez A, Golberg D, et al. In vitro investigation of the cellular toxicity of boron nitride nanotubes. ACS Nano. 2011;5(5):3800–3810.
   PubMed Web of Science ®Google Scholar
• Rocca A, Marino A, Del Turco S, et al. Pectin-coated boron nitride nanotubes: in vitro cyto-/immune-compatibility on RAW 264.7 macrophages. Biochim Biophys Acta. 2016;1860(4):775–784.
   PubMed Web of Science ®Google Scholar
• Jin E, Li S, Ren M, et al. Boron affects immune function through modulation of splenic T lymphocyte subsets, cytokine secretion, and lymphocyte proliferation and apoptosis in rats. Biol Trace Elem Res. 2017;178(2):261–275.
   PubMed Web of Science ®Google Scholar
• Jin E, Ren M, Liu W, et al. Effect of boron on thymic cytokine expression, hormone secretion, antioxidant functions, cell proliferation, and apoptosis potential via the extracellular signal-regulated kinases 1 and 2 signaling pathway. J Agric Food Chem. 2017;65(51):11280–11291.
   PubMed Web of Science ®Google Scholar
• Jin E, Liu W, Ni T, et al. Effects of boron on serum biochemical indexes and microstructure of immune organs in male obese rats. Wei Sheng Yan Jiu. 2017;46(1):113–119.
   PubMedGoogle Scholar
• Yong-Peng T. Cyclic adenosine monophosphate boric acid complex, preparation method thereof, anti-tumor drug and neutron capture therapy boron agent. China Patent CN107163097A. 2017 Sep 15.
   Google Scholar
• Miyazaki H, Kikuchi A, Koyama Y, et al. Boronate-containing polymer as novel mitogen for lymphocytes. Biochem Biophys Res Commun. 1993;195(2):829–836.
   PubMed Web of Science ®Google Scholar
• Xiao K, Yang K, Wang J, et al. Transcriptional study revealed that boron supplementation may alter the immune-related genes through MAPK signaling in ostrich chick thymus. Biol Trace Elem Res. 2018;189(1):209-223
   Web of Science ®Google Scholar
• Xiao K, Ansari AR, Rehman ZU, et al. Effect of boric acid supplementation of ostrich water on the expression of Foxn1 in thymus. Histol Histopathol. 2015;30(11):1367–1378.
   PubMed Web of Science ®Google Scholar
• Armstrong TA, Spears JW, Lloyd KE. Inflammatory response, growth, and thyroid hormone concentrations are affected by long term boron supplementation in gilts. J Anim Sci. 2001;79(6):1549–1556.
   PubMed Web of Science ®Google Scholar
• Bhavsar SK, Schmidt S, Bobbala D, et al. AMPKα1-sensitivity of Orai1 and Ca(2+) entry in T - lymphocytes. Cell Physiol Biochem. 2013;32:687–698.
   PubMed Web of Science ®Google Scholar
• Petho Z, Balajthy A, Bartok A, et al. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation. Immunol Lett Cell Physiol Biochem. 2013;32(3):687–698.
   PubMedGoogle Scholar
• Suzuki AZ, Ozaki S, Goto J, et al. Synthesis of bisboron compounds and their strong inhibitory activity on store-operated calcium entry. Bioorg Med Chem Lett. 2010;20(4):1395–1398.
   PubMed Web of Science ®Google Scholar
• Dellis O, Mercier P, Chomienne C. The boron-oxygen core of borinate esters is responsible for the store-operated calcium entry potentiation ability. BMC Pharmacol. 2011;11:1–11.
   PubMedGoogle Scholar
• Hall ES, Chi LK, Shaw BR, et al. Preparation and characterization of boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy. Anticancer Res. 1992;12(4):1091–1097.
   PubMedGoogle Scholar
• Binello E, Mitchell RN, Harling OK. T cell uptake for the use of boron neutron capture as an immunologic research tool. Appl Radiat Isot. 2004;61(5):959–962.
   PubMed Web of Science ®Google Scholar
• Mortensen MW, Sørensen PG, Björkdahl O, et al. Preparation and characterization of boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy. Appl Radiat Isot. 2006;64(3):315–324.
   PubMed Web of Science ®Google Scholar
• Moreira VM, Salvador JA, Simões S, et al. Novel oleanolic vinyl boronates: synthesis and antitumor activity. Eur J Med Chem. 2013;63:46–56.
   PubMed Web of Science ®Google Scholar
• Ravi D, Beheshti A, Abermil N, et al. Proteasomal inhibition by ixazomib induces CHK1 and MYC-dependent cell death in T-cell and hodgkin lymphoma. Cancer Res. 2006;64(3):315–324.
   Google Scholar
• Nam JH, Woo JE, Uhm DY, et al. Membrane-delimited regulation of novel background K+ channels by Mg ATP in murine immature B cells. J Biol Chem. 2004;279(20):20643–20654.
   PubMed Web of Science ®Google Scholar
• Kurtoğlu F, Kurtoğlu V, Celik I, et al. Effects of dietary boron supplementation on some biochemical parameters, peripheral blood lymphocytes, splenic plasma cells and bone characteristics of broiler chicks given diets with adequate or inadequate cholecalciferol (vitamin D3) content. Br Poult Sci. 2005;46(1):87–96.
   PubMed Web of Science ®Google Scholar
• Fry RS, Lloyd KE, Jacobi SK, et al. Effect of dietary boron on immune function in growing beef steers. J Anim Physiol Anim Nutr (Berl). 2010;94(3):273–279.
   PubMed Web of Science ®Google Scholar
• Mowery YM, Weinberg JB, Kennedy MN, et al. LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells Friedman DR. Leukemia. 2010;24(9):1580–1587.
   PubMed Web of Science ®Google Scholar
• Lee EC, Fitzgerald M, Bannerman B, et al. Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies. Clin Cancer Res. 2011;17(23):7313–7323.
   PubMed Web of Science ®Google Scholar
• Ke Z, Liang D, Zeng Q, et al. hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway. Cytokine. 2013;62(2):310–321.
   PubMed Web of Science ®Google Scholar
• Bhasker TV, Gowda NK, Mondal S, et al. Boron influences immune and antioxidant responses by modulating hepatic superoxide dismutase activity under calcium deficit abiotic stress in Wistar rats. J Trace Elem Med Biol. 2016;36:73–79.
   PubMed Web of Science ®Google Scholar
• Bhasker TV, Gowda NKS, Pal DT, et al. Influence of boron supplementation on performance, immunity and antioxidant status of lambs fed diets with or without adequate level of calcium. PLoS One. 2017;12:11.
   Web of Science ®Google Scholar
• Paulus A, Masood A, Miller KC, et al. The investigational agent MLN2238 (ixazomib) induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs. Haematol. 2014;165(1):78–88.
   Google Scholar
• Schrader J, Henneberg F, Mata RA, et al. The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design. Science. 2016;353(6299):594–598.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Kobayashi M, Awano T, et al. A new monoclonal antibody against rhamnogalacturonan II and its application to immunocytochemical detection of rhamnogalacturonan II in Arabidopsis roots. Biosci Biotechnol Biochem. 2018;82(10):1780–1789.
   PubMed Web of Science ®Google Scholar
• Nidzworski D, Siuzdak K, Niedziałkowski P, et al. A rapid-response ultrasensitive biosensor for influenza virus detection using antibody modified boron-doped diamond. Sci Rep. 2017;7(1):15707.
   PubMed Web of Science ®Google Scholar
• C D H, Idso JP. Dietary boron as a physiological regulator of the normal inflammatory response: a review and current research progress. J Trace Elem Med. 1990;12(3):221–233.
   Google Scholar
• Akama T; Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents. United States patent US8039450B2. 2011 Oct 18.
   Google Scholar
• Armstrong TA, Spears JW. Effect of boron supplementation of pig diets on the production of tumor necrosis factor-alpha and interferon-gamma. J Anim Sci. 2003;81(10):2552–2561.
   PubMed Web of Science ®Google Scholar
• Rajendran KG, Burnham BS, Chen SY, et al. Anti-inflammatory and anti-osteoporotic activities of base-boronated nucleosides and phosphate-boronated nucleotides in rodents. J Pharm Sci. 1994;83(10):1391–1395.
   PubMed Web of Science ®Google Scholar
• Kızılay Z, Erken HA, Çetin NK, et al. Boric acid reduces axonal and myelin damage in experimental sciatic nerve injury. Neural Regen Res. 2016;11(10):1660–1665.
   PubMed Web of Science ®Google Scholar
• Dobmeyer R. Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound. WIPO patent WO2017102565A1. 2017 Jun 22.
   Google Scholar
• Scorei ID, Scorei RI. Calcium fructoborate helps control inflammation associated with diminished bone health. Biol Trace Elem Res. 2013;155(3):315–321.
   PubMed Web of Science ®Google Scholar
• Das BC, Thapa P, Karki R, et al. Boron chemicals in diagnosis and therapeutics. Future Med Chem. 2013;5(6):653–676.
   PubMed Web of Science ®Google Scholar
• Evamarie Hey-Hawkins; Universitat Leipzig. Boron compounds as inhibitors of lipoxygenase and the lipoxygenase pathway, and preparation and use thereof. European Patent Office EP3365347A1. 2018 Aug 29.
   Google Scholar
• Benkovic S, Liu C Synergistic benzoxaborole-containing anti-fungicidal composition. CA2981773 (A1). 2016 Oct 13.
   Google Scholar
• Raines RT, Windsor I, Palte M, et al. Boronic acid inhibitor of HIV protease. US20170327517. 2017 Nov 16.
   Google Scholar
• Korkegian A, O‘Malley T, Xia Y, et al. The 7-phenyl benzoxaborole series is active against mycobacterium tuberculosis. Tuberculosis (Edinb). 2018;108:96–98.
   PubMed Web of Science ®Google Scholar
• Nguyen NQ, Krishnan NP, Rojas LJ, et al. Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030. Antimicrob Agents Chemother. 2016;60(3):1760–1767.
   PubMed Web of Science ®Google Scholar
• Gumbo M, Beteck RM, Mandizvo T, et al. Cinnamoyl-oxaborole amides: synthesis and their in vitro biological activity. Molecules. 2018;23:8.
   Web of Science ®Google Scholar
• Fry RS, Brown TT, Lloyd KE, et al. Effect of dietary boron on physiological responses in growing steers inoculated with bovine herpesvirus type-1. Res Vet Sci. 2011;90(1):78–83.
   PubMed Web of Science ®Google Scholar
• Bourgeois AC, Scott ME, Sabally K, et al. Low dietary boron reduces parasite (nematoda) survival and alters cytokine profiles but the infection modifies liver minerals in mice. J Nutr. 2007;137(9):2080–2086.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Supuran CT, Winum JY. Benzoxaborole compounds for therapeutic uses: a patent review (2010–2018). Expert Opin Ther Pat. 2018;28(6):493–504.
   PubMed Web of Science ®Google Scholar
• Leśnikowski ZJ. Challenges and opportunities for the application of boron clusters in drug design. J Med Chem. 2016;59(17):7738–7758.
   PubMed Web of Science ®Google Scholar
• Carpenter BL, Situ X, Scholle F, et al. Antiviral, antifungal and antibacterial activities of a BODIPY-based photosensitizer. Molecules. 2015;20(6):10604–10621.
   PubMed Web of Science ®Google Scholar
• Lomovskaya O, Sun D, Rubio-Aparicio D, et al. Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in enterobacteriaceae. Antimicrob Agents Chemother. 2017;61(11):1443–1460.
   PubMed Web of Science ®Google Scholar
• Steele C, Fidel P. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 2002;70:577–583.
   PubMed Web of Science ®Google Scholar
• Brittingham A, Wilson WA. The antimicrobial effect of boric acid on Trichomonas vaginalis. Sex Transm Dis. 2014;41(12):718–722.
   PubMed Web of Science ®Google Scholar
• Zeron Mullins M, Trouton KM. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial. Trials. 2015;16:315.
   PubMed Web of Science ®Google Scholar
• Didsbury JR, Dyakonov T, Haydar SN, et al. Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof. WIPO patent WO2007134169A2. 2007 Nov 22.
   Google Scholar
• Konstantinovna D. Composition containing glucosamine, calcium fructoborate and vitamin d for the treatment and/or prophylaxis of disorders related to inflammatory joint diseases, use of said composition, and method for the treatment and/or prophylaxis of disorders related to inflammatory diseases of the joints and spine. WIPO patent WO2016092377A2. 2016 Jun 16.
   Google Scholar
• Hunter JM; VDF FutureCeuticals Inc. Improved compositions and methods for fructoborate complexes. European Patent Office EP2990058B1. 2017 Mar 8.
   Google Scholar
• Akama T, Virtucio C, Dong C, et al. Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent. Bioorg Med Chem Lett. 2013;23(6):1680–1683.
   PubMed Web of Science ®Google Scholar
• Luan Q, Desta T, Chehab L, et al. Inhibition of experimental periodontitis by a topical boron-based antimicrobial. J Dent Res. 2008;87(2):148–152.
   PubMed Web of Science ®Google Scholar
• Yazıcı S, Akşit H, Korkut O, et al. Effects of boric acid and 2-aminoethoxydiphenyl borate on necrotizing enterocolitis. J Pediatr Gastroenterol Nutr. 2014;58(1):61–67.
   PubMed Web of Science ®Google Scholar
• Hazman Ö, Bozkurt MF, Fidan AF, et al. The effect of boric acid and borax on oxidative stress, inflammation, ER stress and apoptosis in cisplatin toxication and nephrotoxicity developing as a result of toxication. Inflammation. 2018;41(3):1032–1048.
   PubMed Web of Science ®Google Scholar
• Demirci S, Doğan A, Karakuş E, et al. Boron and poloxamer (F68 and F127) containing hydrogel formulation for burn wound healing. Biol Trace Elem Res. 2015;168(1):169–180.
   PubMed Web of Science ®Google Scholar
• Katsnelson MA, Rucker LG, Russo HM, et al. K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling. J Immunol. 2015;194(8):3937–3952.
   PubMed Web of Science ®Google Scholar
• Baldwin AG, Rivers-Auty J, Daniels MJD, et al. Boron-based inhibitors of the NLRP3 inflammasome. Cell Chem Biol. 2017;24(11):1321–1335.
   PubMed Web of Science ®Google Scholar
• Baldwin AG, Tapia VS, Swanton T, et al. Design, synthesis and evaluation of oxazaborine inhibitors of the NLRP3 Inflammasome. ChemMedChem. 2018;13(4):312–320.
   PubMed Web of Science ®Google Scholar
• Brough D; University of Manchester. Cyclic diarylboron derivatives as nlrp3 inflammasome inhibitors. WO2017017469A1. 2017 Feb 02.
   Google Scholar
• Surup F, Chauhan D, Niggemann J, et al. Activation of the NLRP3 inflammasome by hyaboron, a new asymmetric boron-containing macrodiolide from the myxobacterium hyalangium minutum. ACS Chem Biol. 2018 Oct 19;13(10):2981–2988.
   PubMed Web of Science ®Google Scholar
• Bello M, Guadarrama-García C, Velasco-Silveyra LM, et al. Several effects of boron are induced by uncoupling steroid hormones from their transporters in blood. Med Hypotheses. 2018;118:78–83.
   PubMed Web of Science ®Google Scholar
• González DA, Díaz BB, Rodríguez Pérez MC, et al. Sex hormones and autoimmunity. Immunol Lett. 2010 Sep 6;133(1):6–13.
   PubMed Web of Science ®Google Scholar
• Merchant T, Coronado DJ, Lee CE, et al. Anacor Pharmaceuticals Inc. Topical pharmaceutical formulations for treating inflammatory-related conditions. United States Patent. US20170152273A1. 2017 Jun 01.
   Google Scholar
• Paton DM. Crisaborole: phosphodiesterase inhibitor for treatment of atopic dermatitis. Drugs Today (Barc). 2017;53(4):239–245.
   PubMed Web of Science ®Google Scholar
• Dong C, Virtucio C, Zemska O, et al. Treatment of skin inflammation with benzoxaborole phosphodiesterase inhibitors: selectivity, cellular activity, and effect on cytokines associated with skin inflammation and skin architecture changes. J Pharmacol Exp Ther. 2016;358(3):413–422.
   PubMed Web of Science ®Google Scholar
• Shirley M. Ixazomib: first Global Approval. Drugs. 2016;76(3):405–411.
   PubMed Web of Science ®Google Scholar
• Al-Homsi AS, Goodyke A, McLane M. Post-transplantation cyclophosphamide and ixazomib combination rescues mice subjected to experimental graft-versus-host disease and is superior to either agent alone. Biol Blood Marrow Transplant. 2017;23(2):255–261.
   PubMed Web of Science ®Google Scholar
• Stadlbauer S; Universitat Leipzig. Compounds containing carbaborane residues and the use thereof in medicine, especially for use in tumour therapy. WIPO patent WO2009021978A2. 2009 Feb 19.
   Google Scholar
• Field-Smith A, Morgan GJ, Davies FE. Bortezomib (Velcade™) in the treatment of multiple myeloma. Ther Clin Risk Manag. 2006;2(3):271.
   PubMedGoogle Scholar
• Yinghuai Z, Lin X, Xie H, et al. The current status and perspectives of delivery strategy for boron-based drugs. Curr Med Chem. 2018;25. DOI:10.2174/0929867325666180904105212.
   Google Scholar
• Guangdi Wang X; University of Louisiana. Boronic derivatives hydroxamates as anticancer agents. WIPO patent WO2018102261A2. 2018 Jun 07.
   Google Scholar
• Gois P, Santos F; Hovione Scientia Limited. Boronated multifunctional targeting drug conjugates, their uses and methods for their preparation. WO2018158582A1. 2018 Sep 7.
   Google Scholar
• Mukkaram-Ali M; Pfizer Inc. Therapeutic particles with peptide boronic acid or boronate ester compounds and methods of making and using same. WIPO patent WO2018073790A1. 2018 Apr 26.
   Google Scholar
• Hiratsuka J, Kamitani N, Tanaka R, et al. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease, with curative clinical response. Cancer Commun. 2018;38:38.
   Web of Science ®Google Scholar
• Boonstra PS, Polk A, Brown N, et al. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. Am J Hematol. 2017;92(12):1287–1294.
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Gay F, Schjesvold F, et al. TOURMALINE-MM3 study group. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2019;393(10168):253–264.
   PubMed Web of Science ®Google Scholar
• Huang P, Lee MW Jr, Sadrerafi K, et al. MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866. Drug Des Devel Ther. 2017;11:629–641.
   PubMed Web of Science ®Google Scholar
• Zane LT, Chanda S, Jarnagin K, et al. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. Immunotherapy. 2016;8(8):853–866.
   PubMed Web of Science ®Google Scholar
• Charles EL, Zarela YS, Tejal M, et al. Anacor Pharmaceuticals Inc. Topical pharmaceutical, formulations to treat inflammatory conditions. AR106847A1. 2018 Feb 21.
   Google Scholar
• Emanet M, Ş Ö, Mustafa Ç. Evaluation of boron nitride nanotubes and hexagonal boron nitrides as nanocarriers for cancer drugs. Nanomedicine. 2017;12(7):797–810.
   PubMed Web of Science ®Google Scholar
• Salvetti A, Rossi L, Iacopetti P, et al. In vivo biocompatibility of boron nitride nanotubes: effects on stem cell biology and tissue regeneration in planarians. Nanomedicine. 2015;10(12):1911–1922.
   PubMed Web of Science ®Google Scholar
• Ciofani G, Danti S, Genchi GG, et al. Boron nitride nanotubes: biocompatibility and potential spill‐over in nanomedicine. Small. 2013;9(9‐10):1672–1685.
   PubMed Web of Science ®Google Scholar
• Hosmane NS. Boron science: new technologies and applications. Boca Raton, FL, USA: CRC press; 2016.
   Google Scholar
• Kuzmanic LA, Zuidema LE, Misurelli JA, et al. Synthesis and biological evaluation of fluorescein-tagged 1-methyl-o-carborane for boron neutron capture therapy. Ann Adv Chem. 2018;2:075–081.
   Google Scholar
• Hey-Hawkins E, Teixidor CV. Boron-based compounds: potential and emerging applications in medicine. Oxford, UK: John Wiley & Sons; 2018.
   Google Scholar
• Soriano-Ursúa MA, Farfán-García ED, Geninatti-Crich S. Turning fear of boron toxicity into boron-containing drug design. Curr Med Chem. 2019. DOI:10.2174/0929867326666190327154954
   PubMedGoogle Scholar